| Literature DB >> 28123141 |
Phuong Hoai Hoang1, Sharda Prasad Awasthi, Phuc DO Nguyen, Ngan Ly Hoang Nguyen, Dao Thi Anh Nguyen, Ninh Hoang LE, Chinh VAN Dang, Atsushi Hinenoya, Shinji Yamasaki.
Abstract
In this study, we attempted to isolate Escherichia coli from healthy adults in Ho Chi Minh City, Vietnam, and characterized its antimicrobial resistance profile, extended-spectrum β-lactamase (ESBL) genotype, phylogenetic grouping and virulence gene profile. A total of 103 E. coli isolates were obtained, and most of them were antimicrobial resistant such to streptomycin (80.6%), tetracycline (67.0%), ampicillin (65.0%), sulfamethoxsazole/trimethoprim (48.5%), nalidixic acid (43.7%), chloramphenicol (34.0%), cefotaxime (15.5%), ciprofloxacin (15.5%), kanamycin (12.6%), ceftazidime (10.7%), fosfomycin (4.9%) and gentamicin (2.9%). However, all these E. coli strains were susceptible to imipenem. Surprisingly, of 103 strains, 74 (71.8%) and 43 (41.7%) strains showed resistance to more than 3 and 5 classes of antimicrobials, respectively. Furthermore, 10 E. coli strains were ESBL-producers and positive for blaCTX-M genes (7 for blaCTX-M-9 and 3 for blaCTX-M-1), while five were additionally positive for blaTEM genes. S1-nuclease pulsed-field gel electrophoresis analysis revealed that 7 and 3 strains of E. coli carry blaCTX-M genes on their large plasmid and chromosome, respectively. Phylogenetic analysis exhibited that majority of the E. coli strains was grouped into A (44.7%), followed by B1 (23.3%), B2 (18.4%) and D (13.6%). Virulence genes associated with diarrheagenic E. coli, such as astA, EAF, eaeA, elt and eagg were also detected in ESBL-producing E. coli as well as antimicrobial resistant strains. These data suggest that commensal E. coli of healthy human could be a reservoir for antimicrobial resistance determinants and some of them might be harmful to human.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28123141 PMCID: PMC5383165 DOI: 10.1292/jvms.16-0639
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Antimicrobial resistant E. coli strains isolated from healthy adults fecal samples (n=103)
| AMPa) | CTXb) | CAZc) | IPMd) | NALe) | CIPf) | GENg) | KANh) | STRi) | FOSj) | TETk) | SXTl) | CHLm) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of isolates | 67 | 16 | 11 | 0 | 45 | 16 | 3 | 13 | 83 | 5 | 69 | 50 | 35 |
| % | 65.0 | 15.5 | 10.7 | 0.0 | 43.7 | 15.5 | 2.9 | 12.6 | 80.6 | 4.9 | 67.0 | 48.5 | 34.0 |
a) ampicillin, b) cefotaxime, c) ceftazidime, d) imipenem, e) nalidixic acid, f) ciprofloxacin, g) gentamicin, h) kanamycin, i) streptomycin, j) fosfomycin, k) tetracycline, l) trimethoprim-sulphamethoxazole, m) chloramphenicol.
Characteristics of E. coli strains, isolated from the fecal samples of healthy adults, carrying ESBL and/or virulence genes
| Isolate ID | Place | Phylogenetic group | Virulence genea) | Antimicrobial resistance phenotype | β-lactamase genes | Location of |
|---|---|---|---|---|---|---|
| E33 | District 3 | A | NDb) | AMP-CTX-CAZ | Plasmid | |
| E42 | Tan Phu | A | AMP-CTX-NAL-TET-SXT | Chromosome | ||
| E55 | Tan Phu | D | AMP-CTX-NAL-SXT-STR | Plasmid | ||
| E66 | Tan Phu | A | ND | AMP-CTX-CAZ-NAL-TET-SXT-STR-CHL | Plasmid | |
| E95 | District 6 | B1 | ND | AMP-CTX-CAZ-NAL-TET-SXT-CIP | Chromosome | |
| E96 | District 6 | D | ND | AMP-CTX-NAL-TET-SXT-STR-CHL-CIP | Chromosome | |
| E97 | District 6 | B1 | AMP-CTX-NAL-KAN | Plasmid | ||
| E100 | District 6 | B1 | AMP-CTX-NAL-KAN | Plasmid | ||
| E101 | District 6 | B1 | AMP-CTX-NAL-KAN | Plasmid | ||
| E137 | Cu Chi | B2 | ND | AMP-CTX-NAL-TET-SXT-STR-CIP | Plasmid | |
| E21 | District 3 | A | NAL | NAc) | NA | |
| E23.13 | District 3 | B1 | AMP-CHL-SXT | NA | NA | |
| E25.13 | District 3 | A | AMP-CHL-CIP-FOS-GEN-KAN-NAL-STR-TET-SXT | NA | NA | |
| E35.13 | Tan Phu | A | CHL-KAN-STR-TET-SXT | NA | NA | |
| E41.13 | Tan Phu | D | AMP-CTX-CAZ-CIP-NAL-STR-TET | NA | NA | |
| E48.13 | Tan Phu | B1 | EAF | AMP-STR-TET | NA | NA |
| E62.13 | Tan Phu | A | FOS-STR | NA | NA | |
| E63.13 | Tan Phu | A | AMP-STR-TET-SXT | NA | NA | |
| E64.13 | Tan Phu | A | EAF | AMP-CHL-FOS-STR-TET-SXT | NA | NA |
| E65.13 | Tan Phu | A | EAF | KAN-NAL-TET | NA | NA |
| E135.13 | Cu Chi | B1 | STR | NA | NA | |
| E136.13 | District 3 | D | AMP-CHL-STR-TET-SXT | NA | NA | |
| E153.13 | Cu Chi | B1 | AMP-CHL-CIP-KAN-NAL-STR-TET-SXT | NA | NA |
a) eaeA (E. coli-attaching and effacing), EAF (enteropathogenic E. coli adherence factor), elt (heat-labile enterotoxin), eagg (plasmid of enteroaggregative E. coli), astA (enteroaggregative stable enterotoxin). b) not detected, c) not applicable.
Fig. 1.Location of the bla genes in ESBL-producing E. coli strains isolated from fecal samples of healthy humans. Left panel; Separation of S1 nuclease-digested DNAs by PFGE. Right panel; Southern hybridization with a blaCTX-M gene-probe. Lanes: 1, E. coli strain E33; 2, E42; 3, E55; 4, E66; 5, E95; 6, E96; 7, E97; 8, E100; 9, E101; 10, E137. M, XbaI-digested DNA from S. enterica serotype Braenderup strain H9812 used as molecular size markers.